☸️ SAIMSARA — Public Sessions

Impella is not a simple “more support means better outcome” device: across 194 references and 432 original studies, the evidence shows a constant trade-off between ventricular unloading, survival signals, and complications such as bleeding, hemolysis, thrombocytopenia, vascular injury, and acquired von Willebrand syndrome. The full ☸️SAIMSARA evidence map shows where Impella appears strongest — early AMI-cardiogenic shock support, high-risk PCI, bridge-to-transplant/LVAD pathways, and selected RV failure scenarios — and where the evidence remains fragile, observational, or safety-limited.

Alcohol and depression are not a simple “alcohol causes depression” story: across 185 references and 3,711 original studies, the evidence separates moderate-use signals from the consistent harms of heavy drinking, AUD, coping-motivated use, suicidality, relapse, and mortality. The full ☸️SAIMSARA evidence map gives a reference-linked view of where causality remains uncertain, which mechanisms matter clinically, and why integrated screening and treatment are needed instead of treating alcohol and depression as separate problems.

Electronic health records are not won by one “best” vendor: the evidence shows that usability, clinical decision support, interoperability, analytics readiness, workflow fit, and governance decide whether an EHR actually improves care. Built from 57 references and 130 original studies, the full ☸️SAIMSARA evidence map gives a practical, reference-linked view of what makes EHR systems work — and where they fail in real clinical settings.

Behçet’s disease is far more than recurrent mouth ulcers: this evidence map shows it as a whole-body inflammatory vasculitis that can threaten vision, veins, arteries, brain, gut, and quality of life. The full review explains which diagnostic signals, genetic mimics, and modern therapies — especially anti-TNF agents, apremilast, colchicine, and emerging JAK inhibitors — may change how Behçet’s disease is recognized and treated.

Cosmetic botulinum toxin is not just “wrinkle treatment”: this evidence map shows where it works, where technique and anatomy decide outcomes, and where real safety risks emerge from unregulated products, poor training, or weak counseling. Built from 201 references and 304 original studies, the full map gives a practical, reference-linked view of efficacy, complications, patient satisfaction, technique choices, and regulatory gaps for modern aesthetic practice.

Roblox, Minecraft, and Fortnite are no longer just games — this evidence map shows how they function as learning spaces, social-development environments, advertising channels, and child-safety risk zones at the same time. Built from 46 references, 32 original studies, and 13,812 participants/sample observations, the full map helps readers separate measurable educational and social benefits from monetization, harmful-content, harassment, and gaming-disorder concerns.

Laser epilation is no longer just a cosmetic hair-removal procedure — this evidence map shows how it extends into pilonidal disease prevention, reconstructive surgery, trichiasis care, inflammatory follicular disorders, and phototype-adapted clinical practice. Built from **83 references and 113 original studies**, the full map helps readers see where laser hair removal is effective, where durability remains uncertain, and where safety risks such as ocular injury, burns, paradoxical hypertrichosis, pigmentary effects, and topical-anesthetic toxicity require protocol-driven care.

Air pollution is not just background exposure — this evidence map shows how PM2.5 and traffic-related pollution repeatedly align with CIMT progression, coronary calcium, plaque phenotype, cardiovascular events, and mechanistic vascular injury. Built from 96 references and 186 original studies, the full map gives a practical view of which vascular endpoints are most consistently affected, which populations appear vulnerable, and where prevention or exposure-reduction research should move next.

AI medical device safety is no longer just about model accuracy — this evidence map shows why real risk emerges across the full lifecycle: retraining, workflow integration, postmarket surveillance, cybersecurity, and human oversight. Built from 146 references and 151 original studies, the full map gives a practical view of where AI medical devices are already improving safety, where reporting and regulation still fail, and which safeguards matter before deployment.

LLM documentation is not simply “safe” or “unsafe”: this evidence map shows where hallucination risk becomes measurable, where it falls below human benchmarks, and which safeguards actually matter—RAG, verification loops, fine-tuning, and human review. Built from 46 references and 32 original studies, it turns scattered clinical AI documentation evidence into a practical safety map for deciding whether, where, and how LLMs should enter real clinical workflows.

ChatGPT vs Claude is not a contest with one winner: the evidence map shows that model performance flips by task, version, modality, and risk level across medicine, education, coding, safety, and research workflows. The full evidence map turns scattered benchmark studies into a practical guide for choosing the right model, identifying where human oversight is essential, and understanding where each system actually performs best.

LinkedIn and Twitter/X are not interchangeable platforms: this evidence map shows where LinkedIn better supports professional identity, recruitment, institutional signaling, and provider-targeted outreach, while Twitter/X more often drives rapid dissemination, public conversation, and broader engagement. The full read turns scattered studies across healthcare, academia, business, government, and computational research into a practical platform-by-platform guide for choosing the right channel, audience, and outcome.